Ogalvibart [2599039-60-6]

TargetMol Chemicals

Ogalvibart [2599039-60-6]

9

2599039-60-6

Research Use Only

Ogalvibart

Ogalvibart (C-135-LS), a humanized anti-SARS-CoV-2 IgG1 type monoclonal antibody, specifically targets and binds to the spike (S) glycoprotein receptor-binding domain (RBD) of the SARS-CoV-2 virus. When combined with C144LS in a 1:1 ratio, Ogalvibart demonstrates significant preventive activity and effectively prevents the progression of COVID-19 in a rhesus monkey disease model [1].

3 years

-20°C

12352203